1,3-Dibromoimidazo[1,5-a]pyridine, 95.0%, 10g

2-(Methylthio)-8-nitro-6-(trifluoromethyl)-4H-benzo[e][1,3]thiazin-4-one, 96%, 250mg

1-Cbz-DL-beta-Prolinol, 95.0%, 1g

1-Ethyl-4-(methoxycarbonyl)pyridin-1-ium iodide, 98%, 1g

Testa da discussione senza oculari. Fornito con due oculari quando la testa viene ordinata insieme al microscopio

1-(3-Butyn-1-yl)pyrrolidine, 95%, 500mg

(2S,3S,4S,5R,6S)-6-{[4,6-dihydroxy-2-(4-hydroxyphenyl)-5-oxo-5H-chromen-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid, 95%, 5g

1,2,3,4-Tetrahydroacridine, 95.0%, 5g

4-phenyl-3-(trifluoromethyl)-1H-pyrazol-5-amine hydrochloride, 95.0%, 250mg

1-(tert-Butoxycarbonyl)-3-hydroxyazetidine>96.0%(GC)1g

h-d-tyr-ome.hcl, 98.0%, 100g

3-BROMOPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXYLIC ACID, 95.0%, 5g

Ammonio cerio(IV) solfato diidrato, minimo 99%, pa, 100 g, confezione in plastica.